Skip to main content
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.550
+0.100 (6.90%)
At close: Jun 18, 2025, 4:00 PM
1.670
+0.120 (7.74%)
Pre-market: Jun 20, 2025, 5:59 AM EDT

Citius Oncology Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Citius Oncology stock have an average target of 6, which predicts a 287.1% increase from the current stock price of 1.55.

Price Target: $6 (+287.1%)
Analyst Consensus: Buy
Target Low Average Median High
Price $6.00 $6.00 $6.00 $6.00
Change +287.10% +287.10% +287.10% +287.10%
* Price targets were last updated on Aug 13, 2024.

Analyst Ratings

The average analyst rating for Citius Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Mar '25Apr '25May '25Jun '25
Strong Buy 2211
Buy 0000
Hold 0011
Sell 0000
Strong Sell 0000
Total 2222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Michael Okunewitch
Maxim Group
 Maxim Group
Hold
Downgrades
n/a
 Hold Downgrades n/a n/a May 23, 2025
Michael Okunewitch
Maxim Group
 Maxim Group
Strong Buy
Initiates
$3
 Strong Buy Initiates $3 +93.55% Nov 27, 2024
Jason Kolbert
EF Hutton
 EF Hutton
Strong Buy
Maintains
$6
 Strong Buy Maintains $6 +287.10% Aug 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 106.16M
Revenue Next Year
n/a
EPS This Year
-0.24
from -0.31
EPS Next Year
-0.03
from -0.24
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025 Sep 30, 2026 Sep 30, 2027
Revenue
 29.26M74.34M106.16M
Revenue Growth
 -154.11%42.80%---
EPS
 -0.32-0.19-0.31-0.24-0.030.44
EPS Growth
 ------
Forward PE
 -----3.53
No. Analysts
 ---333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 30.1M 76.5M 109.3M
Avg 29.3M 74.3M 106.2M
Low 28.1M 71.4M 102.0M

Revenue Growth

Revenue Growth 202520262027
High
-71.6%
161.6%
47.0%
Avg
-72.4%
154.1%
42.8%
Low
-73.5%
144.1%
37.2%

EPS Forecast

EPS 202520262027
High -0.25 -0.03 0.45
Avg -0.24 -0.03 0.44
Low -0.24 -0.03 0.42

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.